Ignite Creation Date:
2024-05-06 @ 9:44 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03051672
Status:
TERMINATED
Last Update Posted:
2021-04-27
First Post:
2017-02-08
Brief Title:
Phase II PEMBROLIZUMAB PALLIATIVE RADIOTHERAPY IN BC
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-11
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-08
First Submit QC Date:
February 9 2017
Study First Post Date:
2017-02-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-04-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-31
Last Update Post Date:
2021-04-27
Last Update Post Date Type:
ACTUAL